跳至主要内容
临床试验/NCT02092857
NCT02092857已完成1 期

Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants

University of Alberta2 个研究点 分布在 1 个国家目标入组 89 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
89
试验地点
2
主要终点
Number of Antigen-presenting B Cells

研究概览

简要总结

The immune system of newborn infants is immature with low activity of both innate and acquired immune reactions. Early nutrition has an impact on early immune responses. Dietary fatty acids are one nutritional factor noted to play a role in immune function. The omega-6 long-chain polyunsaturated fatty acid, ARA (Arachidonic acid) and the omega-3 fatty acid, DHA (docosahexaenoic acid) are found naturally in breastmilk and some infant formulas. The balance or relative amounts of ARA and DHA have been associated with immune response. Some commercial infant formula contains both ARA and DHA. However, the optimal balance of ARA and DHA has not been determined with respect to immune function. This study will assess two levels of ARA and the impact on immune response in healthy, term infants and whether genes that influence essential fatty acid metabolism alter the nutritional requirement of infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
14 Days 至 21 Days(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Antigen-presenting B Cells

时间窗: 10 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验